Physician profile
Daniel B Goldish
NPI 1124413554
$6,387.65
in general payments reported to CMS, 2019-2025
7 companies · $424 in 2025
The $424 reported for 2025 was more than what 76% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,331 · 2021: $219 · 2022: $215 · 2023: $147 · 2024: $1,050 · 2025: $424.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,154 · Food and Beverage: $467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,154.46 |
| Food and Beverage | $467.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,344.14 | 2019-2022 | |
| Fujifilm Sonosite, INC. | $1,200.00 | 2019 | |
| Si-Bone, INC. | $1,032.96 | 2024 | |
| Medtronic USA, INC. | $773.15 | 2019 | |
| Boston Scientific Corporation | $642.80 | 2022-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $316.86 | 2021-2023 | Activos 10 Bone Cement, Kyphon Express II Kyphopak Tray |
| Lilly USA, LLC | $77.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Goldish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.